| Dr Lisa L Guyot, MD PHD | |
|
841 Health Park Boulevard, Grand Blanc, MI 48439-7383 | |
| (810) 606-7340 | |
| (810) 606-7770 |
| Full Name | Dr Lisa L Guyot |
|---|---|
| Gender | Female |
| Speciality | Neurosurgery |
| Experience | 30 Years |
| Location | 841 Health Park Boulevard, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639144736 | NPI | - | NPPES |
| 1402510642 | Other | MI | BLUE CROSS BLUE SHIELD |
| 0992728 | Other | MI | HEALTH PLUS |
| 4568737 | Medicaid | MI | |
| P00090552 | Other | GA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | LG063620 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension At Home | Grand blanc, MI | Home health agency |
| Genesys Regional Medical Center - Health Park | Grand blanc, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesys Practice Partners Inc | 3476456492 | 36 |
News Archive
Inovalon Holdings, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, today announced the list of organizations supported through its charitable contributions during 2014.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.
Researchers from the University of Hawai'i at Mānoa and the State of Hawai'i Department of Health have developed and applied a new technology in Hawai'i that identifies where coral reef ecosystems and associated fisheries are vulnerable to human activities and where to focus management actions to minimize anthropogenic impacts.
It is the double strands of our genes that make them so strong. Using a technique known as DNA origami, biophysicist Hendrik Dietz has been building nanometer-scale objects for several years at the Technical University of Munich.
› Verified 6 days ago
| Entity Name | Genesys Practice Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982647004 PECOS PAC ID: 3476456492 Enrollment ID: O20040128000729 |
News Archive
Inovalon Holdings, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, today announced the list of organizations supported through its charitable contributions during 2014.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.
Researchers from the University of Hawai'i at Mānoa and the State of Hawai'i Department of Health have developed and applied a new technology in Hawai'i that identifies where coral reef ecosystems and associated fisheries are vulnerable to human activities and where to focus management actions to minimize anthropogenic impacts.
It is the double strands of our genes that make them so strong. Using a technique known as DNA origami, biophysicist Hendrik Dietz has been building nanometer-scale objects for several years at the Technical University of Munich.
› Verified 6 days ago
| Entity Name | Lisa L Guyot Md Phd Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023224797 PECOS PAC ID: 9234121492 Enrollment ID: O20040330001651 |
News Archive
Inovalon Holdings, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, today announced the list of organizations supported through its charitable contributions during 2014.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.
Researchers from the University of Hawai'i at Mānoa and the State of Hawai'i Department of Health have developed and applied a new technology in Hawai'i that identifies where coral reef ecosystems and associated fisheries are vulnerable to human activities and where to focus management actions to minimize anthropogenic impacts.
It is the double strands of our genes that make them so strong. Using a technique known as DNA origami, biophysicist Hendrik Dietz has been building nanometer-scale objects for several years at the Technical University of Munich.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa L Guyot, MD PHD 841 Health Park Boulevard, Grand Blanc, MI 48439-7383 Ph: (810) 606-7340 | Dr Lisa L Guyot, MD PHD 841 Health Park Boulevard, Grand Blanc, MI 48439-7383 Ph: (810) 606-7340 |
News Archive
Inovalon Holdings, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, today announced the list of organizations supported through its charitable contributions during 2014.
igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.
Researchers from the University of Hawai'i at Mānoa and the State of Hawai'i Department of Health have developed and applied a new technology in Hawai'i that identifies where coral reef ecosystems and associated fisheries are vulnerable to human activities and where to focus management actions to minimize anthropogenic impacts.
It is the double strands of our genes that make them so strong. Using a technique known as DNA origami, biophysicist Hendrik Dietz has been building nanometer-scale objects for several years at the Technical University of Munich.
› Verified 6 days ago
Dr. Avery Michael Jackson Iii, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9400 S Saginaw Rd Ste A, Grand Blanc, MI 48439 Phone: 810-606-7200 Fax: 810-606-7115 |